New combo therapy shows promise for rare lung cancer
NCT ID NCT05380713
First seen Jan 03, 2026 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tested whether adding a low-dose chemotherapy drug to radiation before surgery could boost the immune system's ability to fight mesothelioma, a rare cancer of the lung lining. Thirty adults with good overall health took part. After surgery, some also received two immunotherapy drugs to help prevent the cancer from coming back. The goal was to see if the combination was safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIOMA, MALIGNANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.